Production (Stage)
ICU Medical, Inc.
ICUI
$128.99
-$1.74-1.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.22% | 5.44% | 4.04% | 0.46% | -2.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.22% | 5.44% | 4.04% | 0.46% | -2.10% |
| Cost of Revenue | 3.04% | 2.50% | 4.31% | 0.52% | -3.82% |
| Gross Profit | 15.90% | 11.48% | 3.48% | 0.33% | 1.68% |
| SG&A Expenses | 4.34% | 5.29% | 6.64% | 3.43% | 0.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.40% | 3.32% | 4.88% | 1.27% | -2.54% |
| Operating Income | 257.94% | 103.62% | -25.77% | -31.46% | 38.85% |
| Income Before Tax | 60.51% | 15.69% | -75.87% | -24.48% | -39.29% |
| Income Tax Expenses | 226.39% | 206.23% | 100.28% | 9.68% | -57.10% |
| Earnings from Continuing Operations | -57.96% | -296.86% | -295.83% | -45.98% | -28.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -57.96% | -296.86% | -295.83% | -45.98% | -28.86% |
| EBIT | 257.94% | 103.62% | -25.77% | -31.46% | 38.85% |
| EBITDA | 27.53% | 14.57% | -7.13% | -7.11% | 0.11% |
| EPS Basic | -56.19% | -292.15% | -290.68% | -44.33% | -27.63% |
| Normalized Basic EPS | 117.87% | 76.47% | -75.64% | -122.87% | -32.83% |
| EPS Diluted | -56.62% | -292.64% | -290.49% | -44.37% | -27.56% |
| Normalized Diluted EPS | 117.90% | 76.42% | -76.30% | -122.45% | -32.59% |
| Average Basic Shares Outstanding | 1.34% | 1.23% | 1.02% | 0.94% | 0.80% |
| Average Diluted Shares Outstanding | 1.09% | 0.98% | 0.78% | 1.19% | 1.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |